Oral Cancer Treatment Market Analysis | 2022-2028

“The Oral Cancer Treatment Market was estimated at US$ 1.8 billion in 2021 and is expected to grow at a CAGR of 5.8% during 2022-2028 to reach US$ 3.80 billion in 2028”.

Wish to get a free sample? Register Here

Market Dynamics

Introduction

Oral cancer is another type of deadly disease that has been diversified in terms of various types of oral cancers such as squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinoma, lymphomas, and others that have been proven to be deadly and dangerous in terms of population affected by them. Though oral cancers are non-communicable diseases, they impact a considerable section of the population worldwide.

Market Drivers

The rising global prevalence of oral or mouth cancer is a primary factor driving market expansion. Rising investment in healthcare infrastructure development, rising consumption of tobacco products such as cigarettes, cigars, pipes, and chewing tobacco, and an increase in special designation from regulatory agencies are all factors driving market expansion.

Another indirect variable that would generate profitable market growth potential is rising personal disposable income along with the rising frequency of papillomavirus infection.

The oral cancer treatment market is one of the rapidly improving market structures, with better future results expected due to an increase in the number of cases of oral cancer surgeries, which leads to ongoing investments in the establishment and growth of the oral cancer treatment market size and share. Oral cancer accounts for 4% of all cancer cases and 2.2% of fatalities in the United States.

Oral cancer accounts for 2% to 6% of all cancer cases in Western countries. Furthermore, in Asia-Pacific, men are more likely than women to develop oropharyngeal cancer. According to the National Cancer Institute, 60% of persons with oral cancer live for five years or longer, while 70% to 90% of people with Stage 1 or 2 cancer live for five years or longer.

Increased consumption of tobacco products and alcoholic beverages, which have severe consequences and are regarded as the leading causes of oral cancer among young people worldwide, has been a major key driver that has boosted oral cancer treatment market share and established a favorable trend.

Increased spending on healthcare infrastructure development, increased consumption of tobacco products such as cigarettes, cigars, pipes, and chewing tobacco, and an increase in special designation from regulatory agencies are all factors driving market expansion. Another indirect variable that would provide attractive market growth potential is an increase in personal disposable income combined with an increase in the prevalence of papillomavirus infection.

Another major driver in the global oral cancer treatment market has been the increasing number of health awareness programmes and missions that have motivated people all over the world to improve their health stats and to be aware of the diseases that can be caused by the consumption of various products. Furthermore, advancements in healthcare facilities around the world have aided the oral cancer treatment industry.

However, a lack of awareness regarding oral cancer in backward and impoverished areas would offer a significant barrier to market growth. Furthermore, the high expenditures connected with research and development capabilities, combined with a scarcity of trained individuals, will derail the market's growth rate. in addition to that, the risk of recurrence after treatment hinders the growth of the market. The overall growth in the oral cancer market has been rapid, but certain constraints are impeding the industry's growth, including huge sums of money to be invested initially in the establishment of oral cancer treatment companies, which limits the ability of various new players to enter the markets.

Another major impediment to increasing the market share of oral cancer treatments is the risk associated with cancer treatment and the recurrence of cancer even after treatment, which remains one of the major drawbacks and makes the situation of the patients even worse because cancer can still return being more lethal even after the painful treatment processes and surgeries.

Another major stumbling block that has recently been identified is the high cost of oral cancer treatment, which excludes most patients who do not have adequate financial resources and also affects the oral cancer treatment market share because it cannot cater to a diverse range of patients from various socioeconomic backgrounds.

Several investments/guidelines in the industry have been directed in recent years, which would boost the overall market. Some of them are:

• According to the Oral Cancer Foundation, 53000 new cases of oral cancer are diagnosed each year, with approximately 10000 people dying as a result of the fatal disease. The most common symptoms of oral cancer are normal but clinical, such as a sore throat, gum discomfort, swelling around the lips, and enlargement of the entire face. These symptoms are a strong indication of oral cancer, which if not treated promptly and appropriately can spread to the rest of the body. However, developments in technology and improved healthcare facilities have contributed to an improvement in the oral cancer treatment industry.

Recent Developments

Manufacturers have been concentrating on creating top-notch products to sustain their market position.

For instance:

• In October 2021, Takeda Pharmaceutical Firm bought Gammadelta Therapeutics Limited, a company focused on exploiting unique features of cells for immunotherapy. This would allow the major firm to profit from all of the acquired company's intellectual property.
• In October 2021, Roche will release a new profiling kit that will allow cancer researchers to easily assess tumors without needing to send tissue samples to centralized laboratories. This would be a substantial boost to the market for medical cancer research.

Segments Analysis

By Type

The oral cancer treatment market is segmented into oral squamous cell carcinoma, oral verrucous carcinoma, mucoepidermoid carcinoma, and oral cavity lymphomas.

By Therapy Type

The oral cancer treatment market is segmented into chemotherapy, radiation therapy, and biological therapy.

By Treatment Type

The oral cancer treatment market is segmented into medication and surgery. 

By Route of Administration Type

The oral cancer treatment market is segmented into oral, injectable, and others. 

By End-User Type

The oral cancer treatment market is segmented into hospitals, home care, specialty clinics, and others.

Regional Analysis

“North America holds a dominant position in the oral cancer treatment industry”.

The oral cancer treatment market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Because of the increased affordability of medications and the increase in incidences of mouth cancer, North America dominates the oral cancer treatment industry.

For the forecast period, Asia-Pacific is expected to have the greatest growth rate and CAGR. This is due to rising healthcare infrastructure development costs and rising cigarette consumption.

Key Players

The following are the key players in the Oral Cancer Treatment Market (arranged alphabetically)

• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F Hoffmann-La Roche Ltd
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Qilu Pharmaceutical Co., Ltd
• Teva Pharmaceutical Industries Ltd.

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research:

Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.